Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.
نویسندگان
چکیده
genetic study suggested a lifetime risk of breast cancer of 80–90 per cent. She opted for total abdominal hysterectomy and bilateral salpingooophrectomy, which was performed 8 weeks after the rst operation. The histopathology report revealed a reactive mesothelial cells in the peritoneal washing and a primary adenocarcinoma of the left fallopian tube stump which remained after surgery for the ectopic. After the surgery, she had adjuvant chemotherapy with single agent carboplatin. A year later, clinical and imaging (CT scan) examinations showed no signs of recurrence.
منابع مشابه
Malignant Mixed Mullerian Tumor of the Uterus Associated with Tamoxifen Therapy in a Patient with a History of Breast Cancer
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen. In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use.
متن کاملEvaluation of Factors Related to Short-Term and Long-Term Survival of Breast Cancer Patients by Mixture Cure Model
Introduction: Breast cancer is the most common cancer among women. Today, with advancements in medical sciences, increasing the cure probability of patients as well as increasing survival time is an important goal of cancer treatment. Therefore, in this study, in addition to examining patients’ survival, we investigated the cure probability of breast cancer patients and its prognostic factors u...
متن کاملLong-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
Tamoxifen treatment for breast cancer may induce ovarian cysts and supraphysiological levels of serum estrogen. We report successful management with luteinizing hormone-releasing hormone (LHRH) agonist of ovarian hyperstimulation induced by tamoxifen. A 49-year-old woman was operated on for invasive ductal carcinoma of the right breast. She received breast irradiation and adjuvant tamoxifen the...
متن کاملمیزان بروز آمنوره ناشی از شیمی درمانی ادجوانت در زنان غیریائسه مبتلا به سرطان پستان
Background and purpose: Although adjunct chemotherapy may increase life in non-menopausal breast cancer patients، however، it may cause short-term complications such as nausea، vomiting، alopecia، as well as long-term complications in ovarian failure and premature menopausal. The objective of this study was to investigate chemotherapy-induced secondary amenorrhea in non-menopausal women with br...
متن کاملP-195: Thymoquinone Increases Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer MCF-7 Cells: In Vitro
Background: The objective of this study is to evaluate combined effect of Thymoquinone (The main active component of black seeds) with Tamoxifen drug on apoptosis of human breast cancer MCF-7 cells (Noninvasive human breast cancer cell line, estrogen receptor positive). Materials and Methods: The human breast cancer MCF- 7 cells were treated with Tamoxifen (2 μM) alone or in combination with Th...
متن کاملمقایسه اثرات تاموکسیفن در بروز سنگهای صفراوی در بیماران زن مبتلا به کانسر پستان
Background & Aims: Tamoxifen is used in breast cancer as adjuvant hormonal therapy. Some studies have found effect of tamoxifen on bile components and gallstone formation. The purpose of the study was to find out the association between tamoxifen use in patient with breast cancer and gallstone formation. Materials & Methods: 780 patient with breast cancer who had undergone surgery in 3 hospita...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
دوره 22 5 شماره
صفحات -
تاریخ انتشار 2002